Patient
SITE011-0007
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE011 (ITA) (Dr. Jansen)
consented 2025-09-01
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
moderate
assessed
2026-03-07
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-08-31 (study day 179); relationship: not assessed
severe
assessed
2026-02-01
Grade 3 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-07-28 (study day 145); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.